Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore
Clinical trial NCT02425098 · COMPLETED
Trial details
- NCT number
- NCT02425098
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-03
- Primary completion
- 2017-09-18
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.